Normal and malignant megakaryopoiesis
- 1 March 2011
- journal article
- review article
- Published by Cambridge University Press (CUP) in Expert Reviews in Molecular Medicine
- Vol. 13, e32
Abstract
Megakaryopoiesis is the process by which bone marrow progenitor cells develop into mature megakaryocytes (MKs), which in turn produce platelets required for normal haemostasis. Over the past decade, molecular mechanisms that contribute to MK development and differentiation have begun to be elucidated. In this review, we provide an overview of megakaryopoiesis and summarise the latest developments in this field. Specially, we focus on polyploidisation, a unique form of the cell cycle that allows MKs to increase their DNA content, and the genes that regulate this process. In addition, because MKs have an important role in the pathogenesis of acute megakaryocytic leukaemia and a subset of myeloproliferative neoplasms, including essential thrombocythemia and primary myelofibrosis, we discuss the biology and genetics of these disorders. We anticipate that an increased understanding of normal MK differentiation will provide new insights into novel therapeutic approaches that will directly benefit patients.Keywords
This publication has 173 references indexed in Scilit:
- LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell diseaseNature Cell Biology, 2010
- Distinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 SignalingCancer Cell, 2010
- Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor CellsCancer Cell, 2010
- IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosisLeukemia, 2010
- JAK3: A two-faced player in hematological disordersThe International Journal of Biochemistry & Cell Biology, 2009
- NuRD mediates activating and repressive functions of GATA‐1 and FOG‐1 during blood developmentThe EMBO Journal, 2009
- Mutation inTET2in Myeloid CancersNew England Journal of Medicine, 2009
- Proteomic screen defines the Polo‐box domain interactome and identifies Rock2 as a Plk1 substrateThe EMBO Journal, 2007
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Acute megakaryoblastic leukemia: experience of GIMEMA trialsLeukemia, 2002